Abstract
Serotonin (5-hydroxytryptamine) is believed to play a pathogenic role in skin damage and various skin abnormalities; however, its mechanism of action remains unknown. We show here that intradermal injection of serotonin in rats induced a marked reduction in the activities of the glycolytic enzymes, phosphofructokinase (EC 2.7.1.11) and aldolase (EC 4.1.2.13), in both the cytoskeletal and cytosolic fractions from skin. Serotonin also decreased the levels of glucose 1,6-bisphosphate in skin, the powerful regulator of glucose metabolism. These serotonin-induced changes were accompanied by a marked decrease in ATP content in skin. All these pathological changes induced by serotonin were prevented by treatment with two structurally different calmodulin antagonists: thioridazine, an antipsychotic phenothiazine, or clotrimazole, from the group of the antifungal azole derivatives that were recently recognized as calmodulin antagonists. The present results suggest that calmodulin antagonists may be effective drugs in the treatment of skin damage under various pathological conditions and diseases in which serotonin levels are increased.
References
Mar 10, 1975·Clinica Chimica Acta; International Journal of Clinical Chemistry·W H ThomsonI J Hamilton
Jun 15, 1992·Thrombosis Research·M H PietraszekT Yoshimi
Jun 1, 1991·Biochemical Medicine and Metabolic Biology·V AdamsE R McCabe
Feb 28, 1991·The New England Journal of Medicine·J M Astrachan
Jan 1, 1991·General Pharmacology·R BeitnerY Bassukevitz
Jan 1, 1990·The International Journal of Biochemistry·G Lilling, R Beitner
Jan 1, 1990·The International Journal of Biochemistry·R Beitner
Jan 1, 1989·Current Topics in Cellular Regulation·C MohanS P Bessman
Jan 1, 1989·General Pharmacology·R BeitnerH Ben-Porat
Jan 1, 1989·General Pharmacology·R BeitnerH Morgenstern
May 1, 1969·The Journal of Clinical Investigation·R I WeedE W Merrill
Jun 14, 1974·Nature·J H Wilkinson, J M Robinson
Nov 1, 1968·European Journal of Biochemistry·H Arnold, D Pette
May 1, 1966·The American Journal of Medicine·S P Bessman
Jan 1, 1984·The International Journal of Biochemistry·R Beitner
Nov 15, 1982·The Biochemical Journal·M J WakelamD Pette
Jan 1, 1983·The International Journal of Biochemistry·R BeitnerM Kaplansky
Nov 1, 1980·Journal of Molecular and Cellular Cardiology·J RajsU Söderlund
Oct 1, 1994·General Pharmacology·N Koren-SchwartzerR Beitner
Jul 1, 1993·General Pharmacology·R Beitner, G Lilling
Jan 1, 1994·Clinical and Experimental Dermatology·R C RatnavelR J Pye
Mar 1, 1993·The Journal of Investigative Dermatology·L HegemannJ Uitto
Feb 1, 1993·The British Journal of Dermatology·S Mac NeilD F Tierney
Mar 1, 1993·The International Journal of Biochemistry·R Beitner
Oct 17, 1996·European Journal of Pharmacology·L Glass-MarmorR Beitner
Mar 18, 1960·Acta Physiologica Scandinavica·S A JOHANSSON
Citations
Apr 23, 2003·Molecular Genetics and Metabolism·Gutemberg Gomes Alves, Mauro Sola-Penna
Jan 8, 2008·Experimental Dermatology·Klas NordlindAndrzej Slominski
Dec 27, 2005·Molecular Genetics and Metabolism·Monica M Marinho-CarvalhoMauro Sola-Penna
Aug 13, 1999·Molecular Genetics and Metabolism·M Ashkenazy-Shahar, R Beitner
Jan 28, 2015·Neuroscience and Biobehavioral Reviews·Paul W AndrewsJ Anderson Thomson
Jun 3, 1998·Molecular Genetics and Metabolism·M Assouline-CohenR Beitner
Oct 6, 1998·Molecular Genetics and Metabolism·N Gilboa-Garber, R Kirstein-Segal
Aug 28, 1998·Molecular Genetics and Metabolism·R Beitner
Jan 29, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Andrzej SlominskiDesmond J Tobin
Aug 2, 2007·The Biochemical Journal·Tiago Costa LeiteMauro Sola-Penna